Quoin Pharmaceuticals, Ltd.
QNRX
$5.91
-$0.16-2.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.80M | -13.77M | -12.17M | -10.45M | -8.96M |
| Total Depreciation and Amortization | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 931.50K | 986.60K | 1.05M | 1.09M | 1.01M |
| Change in Net Operating Assets | 1.23M | 1.94M | 323.30K | 239.00K | -2.10K |
| Cash from Operations | -13.54M | -10.74M | -10.70M | -9.02M | -7.86M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.28M | 3.81M | 3.88M | 5.35M | -1.89M |
| Cash from Investing | -4.28M | 3.81M | 3.88M | 5.35M | -1.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -600.00K | -600.00K | -600.00K | -600.00K | -600.00K |
| Issuance of Common Stock | 18.61M | 6.24M | 6.24M | 6.26M | 11.57M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18.01M | 5.64M | 5.64M | 5.66M | 10.97M |
| Foreign Exchange rate Adjustments | -600.00 | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 194.80K | -1.29M | -1.18M | 1.99M | 1.22M |